| Thursday, December 4, 2008 | ||
| 08:00:00 | Registration | Lobby of NBAH | |
| 08:00:00 | New Workshop 1: Social Ethic, Economy, Legal and Regulations of Gene Technology | |
| 13:30:00 | The Reinvention of Prevention Aims, Goals and Scope of Public Health Genetics Revisited | Norbert W . Paul |
| 13:30:00 | Workshop Introduction | |
| 13:40:00 | Working with Biological Material – Laws and Regulations to be Respected | Vera , Weihs |
| 14:05:00 | The Importance of Genetic Counseling and Medical Ethics Issues | Ayşegül Demirhan Erdemir |
| 14:55:00 | Gene Technologies and Ethical issues | Badaruddin Abbasi |
| 15:00:00 | Workshop 2: Gene and Ageing & Longevity | |
| 15:30:00 | Workshop Introduction | |
| 15:40:00 | Physiological Oxidation of a Voltage-gated K+ channel Leads to Progressive Decline in Sensory Function during Ageing in Caenorhabditis elegans | Federico , Sesti |
| 16:05:00 | Alpha-Kinases: From Translational Control to Longevity | Alexey Ryazanov |
| 16:30:00 | Metabolomics to Functional Genomics: Identifying a Common Genetic Control for Vigour and Longevity of Rice Seed | Swati Sen-Mandi |
| 16:55:00 | TBD | Eske Willerslev |
| 17:20:00 | Mapping of Genes Predisposing to Alcohol Sensitivity | Thomas E. Johnson |
| 20:00:00 | End of registration | |
| Friday, December 5, 2008 | ||
| 06:00:00 | Main Conference (5-7) | |
| 06:00:00 | Check-In | |
| 09:00:00 | Chair: | Wenling Zheng |
| 09:30:00 | Roles of the Ubiquitin System in Health and Disease | Avram Hershko |
| 10:00:00 | Recent Paradigm Shift in Understanding Estrogen Signaling Opens up Novel Pharmaceutical Developments | Jan-Åke Gustafsson |
| 10:30:00 | Understanding Chronic Disease Requires Study of a Metagenome, not just the Human Genome | Trevor G Marshall |
| 11:00:00 | Speech addressed by World Leading Companies and Executives (Invited) | |
| 11:30:00 | Speech Addressed by Guangzhou City Governmental Leader (Invited) | |
| 12:00:00 | New Presentation | |
| 13:00:00 | Track 1: Basis and Frontiers of Gene Technology | |
| 13:00:00 | Session Chair : Track 1-6 (I) | Craig Levin |
| 13:00:00 | Track 1-6 (I): Gene Discovery Technologies: Biochips, DNA Micro array, Multiplexed CE, Lab-on-Chips, Gene Trapping and Beyond: Track 1-6 (I) | |
| 13:05:00 | Session Chair : Track 1-4 (II) | Jiang He |
| 13:05:00 | Session Chair : Track 1-4 (I) | |
| 13:05:00 | Track 1-4 (I): RNA Technologies: siRNA, RNAi, microRNAs,mRNA and Antisense | |
| 13:05:00 | Session Chair : Track 1-4 (II) | |
| 13:05:00 | Track 1-4 (II): RNA Technologies: siRNA, RNAi, microRNAs,mRNA and Antisense (II) : Track 1-4 (I) | |
| 13:05:00 | Track 1-3: Functional Genomics: Genomics, Transcriptomics, Proteomics, Metabolomics, Pharmacogenomics and Epigenomics : Track 1-3 | |
| 13:05:00 | Session Chair : Track 1-5 (II) | |
| 13:05:00 | Co-Chair : Track 1-6 (I) | Marlene Shehata |
| 13:05:00 | Track 1-5: SNPs Technologies : Track 1-5 (II) | |
| 13:05:00 | Co-Chair : Track 1-5 (II) | Struan F.A. Grant |
| 13:05:00 | Session Chair : Track 1-2 | Luyi Sen |
| 13:05:00 | Track 1-2: Gene Delivery Technologies | |
| 13:05:00 | Track 1-7: Bioinformatics, Computational Gene Technologies and Systems Biology | |
| 13:05:00 | Session Chair : Track 1-7 | |
| 13:05:00 | Session Chair : Track 1-1 | George Klein |
| 13:05:00 | Track 1-1: Human & Microbial Genetics, Genetic Model Systems and Human Diseases | |
| 13:10:00 | Co-Chair : Track 1-1 | |
| 13:10:00 | Co-Chair : Track 1-7 | Frederic Pio |
| 13:10:00 | Co-Chair : Track 1-2 | |
| 13:10:00 | Session Chair : Track 1-3 | |
| 13:10:00 | Co-Chair : Track 1-4 (I) | |
| 13:10:00 | Co-Chair : Track 1-3 | Akira Kaji |
| 13:10:00 | Co-Chair : Track 1-4 (II) | |
| 13:30:00 | Introduction : Track 1-7 | |
| 13:30:00 | Introduction : Track 1-4 (I) | |
| 13:30:00 | Introduction : Track 1-4 (II) | |
| 13:30:00 | Introduction : Track 1-6 (I) | |
| 13:30:00 | Session Introduction : Track 1-3 | |
| 13:30:00 | Introduction : Track 1-1 | |
| 13:30:00 | Introduction : Track 1-2 | |
| 13:30:00 | Introduction : Track 1-5 (II) | |
| 13:35:00 | Microarray Analytics and Systems Biology: Track 1-7 | Vijay Chandru |
| 13:35:00 | Inhibition of Hepatitis C IRES-Mediated Gene Expression by Small Hairpin RNAs in Human Hepatocytes and Mice: Track 1-4 (II) | Brian H. Johnston |
| 13:35:00 | Non-invasive Imaging Using Reportere Genes: Track 1-6 (I) | Jeff W. M. Bulte |
| 13:35:00 | Only One Speech Opportunity : Track 1-4 (I) | |
| 13:35:00 | Engineering Gene Delivery: Toward Construction of Artificial Viruses : Track 1-2 | Daniel W. Pack |
| 13:35:00 | Molecular Genetics of Neurofibromatosis Type1(NF1) Tumors: Genome-wide Profiling of NF1-associated Tumors : Track 1-1 | Meena Upadhyaya |
| 13:35:00 | Keynote Speech : Track 1-3 | |
| 13:55:00 | Application of Advanced Technologies to Personalized Oncology: Track 1-7 | Francis S Collins |
| 13:55:00 | Epigenetic Analysis of Human Sperm as a Cause of Male Infertility: The Role of Abnormal Chromatin Packaging during Early Embryogenesis : Track 1-3 | Douglas T. Carrell |
| 13:55:00 | From DNA Microarrays to Electronic Biochips: Principles and Advances Potential : Track 1-6 (I) | Arnold Vainrub |
| 13:55:00 | Molecular and Cellular Regulation of 4.1R Pre-mRNA Alternative Splicing During Erythroid Differentiation: Track 1-4 (II) | Faouzi Baklouti |
| 13:55:00 | Escaping Development of Drug-Resistant Mutant: Basis for Effective Chemotherapy of Enteroviral Infections : Track 1-1 | Angel S. Galabov |
| 14:00:00 | Results from Genome Wide Association Studies: Moving Forward with Certainty: Track 1-5 (II) | |
| 14:05:00 | Toxicological Aspects and Applications of Nanoparticles in Paediatric Respiratory Disease : Track 1-2 | John Clements |
| 14:15:00 | The Genetic Etiology of Metabolic Syndrome : Track 1-1 | |
| 14:15:00 | Fluorescence Correlation Spectroscopy and Fluorescence Cross-correlation Spectroscopy Reveal the Cytoplasmic Origination of Loaded Nuclear RISC in vivo in Human Cells: Track 1-4 (II) | |
| 14:15:00 | Analysis of Chromosomal Rearrangements: a Powerful Gene Discovery Approach for Human Diseases: Track 1-6 (I) | Weining Lu |
| 14:15:00 | Targeted Metabolomics in Pharmaceutical R&D : Track 1-3 | Klaus Weinberger |
| 14:15:00 | Title: TBD | Peixuan Guo |
| 14:25:00 | Genetics of Schizophrenia: Real Genes Are Hard to Find: Track 1-5 (II) | Xiangning (Sam) Chen |
| 14:30:00 | A Highly Efficient and Safe Low Strength Electric Field Network Mediated Ex Vivo Gene therapy Strategy : Track 1-2 | Luyi Sen |
| 14:35:00 | RNA Silencing Suppressors : Track 1-4 (II) | |
| 14:35:00 | Genetics and Genomics: Interactions Between on Nutrition and Obesity : Track 1-3 | Alfredo Martínez |
| 14:35:00 | In Vivo Reporter Gene Imaging: Track 1-6 (I) | Craig Levin |
| 14:35:00 | All Type of RNA Assays/Research : Track 1-4 (I) | Ralph Beneke |
| 14:35:00 | Candidate Gene Selection and Gene Networks in Schizophrenia: Track 1-7 | Zhongming Zhao |
| 14:35:00 | Ribosome Recycling Step; The Essential Fourth Step of Protein Synthesis as a Possible Target of Antibiotics and Anti-tumor Agent : Track 1-1 | Hideko Kaji |
| 14:50:00 | SNP Genotyping with DASH, Pyrosequencing and TaqMan: Track 1-5 (II) | |
| 14:55:00 | Speech Opportunity Available : Track 1-7 | |
| 14:55:00 | Nano-sized Vesicles for Targeted Drug Delivery and Gene Therapy : Track 1-2 | Eli Heldman |
| 14:55:00 | Is there genetic cancer resistance? : Track 1-1 | George Klein |
| 14:55:00 | DNA Microarrays in Today's Medical Practice: Track 1-6 (I) | Med. José I. Lao Villadóniga |
| 14:55:00 | The Role of the MicroRNAs During Development and Cancer Progression: Track 1-4 (II) | |
| 15:15:00 | Coffee Break : Track 1-3 | |
| 15:15:00 | Coffee Break : Track 1-4 (II) | |
| 15:15:00 | Coffee Break : Track 1-5 (II) | |
| 15:15:00 | Coffee Break | |
| 15:15:00 | Coffee Break : Track 1-7 | |
| 15:15:00 | Coffee Break | |
| 15:15:00 | Coffee Break : Track 1-2 | |
| 15:15:00 | Coffee Break : Track 1-4 (I) | |
| 15:30:00 | Integrating Structural Bioinformatics and Proteomics Approaches to Discover New Genes, Protein Families, and Function in Apoptosis and Inflammation: Track 1-7 | Frederic Pio |
| 15:30:00 | Association Study of Major Psychiatric Disorders: Track 1-5 (II) | Draga Toncheva |
| 15:30:00 | Topological Origin of Gene Delivery System: Magic Structures for Gene Therapy : Track 1-2 | David V. Svintradze |
| 15:30:00 | MicroRNA-based Regulatory Pathways in Hematopoiesis, Heart Disease and Cancer : Track 1-4 (I) | Cesare Peschle |
| 15:30:00 | Three Additional Functions of Ribosome Recycling Factor-Its Role During the Chain Elongation and for the Initiation of Translationally Coupled ORFs : Track 1-3 | Akira Kaji |
| 15:30:00 | Title: TBD: Track 1-4 (II) | Jiang He |
| 15:30:00 | Assistant Professor, Department of Radiology and Biomedical Imaging, Center for Molecular and Functional Imaging, University of California, USA: Track 1-4 (II) | Jiang He |
| 15:30:00 | The Urofacial Syndrome (UFS), a Unique Model for Dissecting the Mechanism Underlying Voiding Dysfunction : Track 1-1 | Cong-Yi Wang |
| 15:30:00 | De novo Mutations in the Gene Encoding STXBP1 (MUNC18-1) Cause Early Infantile Epileptic Encephalopathy: Track 1-6 (I) | Naomichi Matsumoto |
| 15:50:00 | Microfluidic Devices for Single-cell Analysis: Track 1-6 (I) | John F. Zhong |
| 15:50:00 | MicroRNA Involvement in Murine Mammary Gland Development : Track 1-4 (I) | Qingzhang Li |
| 15:50:00 | Genetics of M&M: Not a Candy Issue At All : Track 1-1 | Volodymyr Dvornyk |
| 15:50:00 | Bio-nanocapsules for in vivo Gene Delivery Possessing Active Targeting and Membrane Fusion Activities : Track 1-2 | Shun'ichi KURODA |
| 15:50:00 | Novel Paradigms for Drug Discovery: Computational Multitarget Screening: Track 1-7 | Ekachai Jenwitheesuk |
| 15:50:00 | Only One Speech Opportunity : Track 1-4 (II) | |
| 15:50:00 | Mice Genome Manipulation : Track 1-3 | Wenhao Xu |
| 15:55:00 | Advance in High-throughput SNPs Technology based on Magnetic Nanoparticles: Track 1-5 (II) | Nongyue He |
| 16:10:00 | Application of New Proteomics Technologies to Drug Discovery : Track 1-3 | Yingming Zhao |
| 16:10:00 | Persistent Genes in Bacterial Genomes and Their Significance in Synthetic Biology: Track 1-7 | Gang Fang |
| 16:10:00 | Speech Opportunity: Track 1-6 (I) | |
| 16:10:00 | Genetics and Epigenetics of Asthma in Chinese Children : Track 1-1 | Leung Ting Fan |
| 16:10:00 | Development of Disease (Bacterial Blight) Resistance in Indica Rice by Agrobacterium Mediated Transformation : Track 1-2 | Harmid Rashid |
| 16:10:00 | Inhibition of Phosphodiesterase Gene Expression by RNAi in the Human Mesenchymal Stem Cell Derived Osteoblasts: Track 1-4 (II) | |
| 16:10:00 | Inhibition of Phosphodiesterase Gene Expression by RNAi in the Human Mesenchymal Stem Cell Derived Osteoblasts: Track 1-4 (II) | Minna , Pekkinen |
| 16:10:00 | RNAi Suppressors from Begomovirus: Biology, Mechanisms and Usages : Track 1-4 (I) | Sunil Kumar Mukherjee |
| 16:20:00 | Searching for Disease Modifying Genes in Thalassemia: Track 1-5 (II) | Suthat Fucharoen |
| 16:30:00 | Insulin Resistance, Salt-sensitive Hypertension and Inflammation: A Trio in Dahl Salt-sensitive Rats: Track 1-6 (I) | Marlene Shehata |
| 16:30:00 | MicroRNA Involvement in Murine Mammary Gland Development: Track 1-4 (II) | Chunmei Wang |
| 16:30:00 | MicroRNA Involvement in Murine Mammary Gland Development: Track 1-4 (II) | Chunmei Wang |
| 16:30:00 | Mitochondri'omics': Mitochondrial Informatics in today's era of Omics: Track 1-7 | Prashanth Suravajhala |
| 16:30:00 | Identification of Novel Modifier Genes of Sox10 Neurocristopathy by a Functional Genomic approach : Track 1-3 | Ling Hou |
| 16:30:00 | Design of Chemically Modified siRNA Targeted Cancer-related Genes : Track 1-4 (I) | Elena L. Chernolovskaya |
| 16:30:00 | Gene Therapy in the Management of Oral Diseases : Track 1-1 | Balwant Rai |
| 16:30:00 | AAV in BAC: The time for large scale AAV vector manufacturing has come : Track 1-2 | Haifeng Chen |
| 16:45:00 | Influence of Single Nucleotide Polymorphisms of RA System on Blood Pressure and Blood Levels of Trace Elements: Track 1-5 (II) | Shahida Hasnain |
| 16:50:00 | Global distribution of miRNA in Soybean : Track 1-4 (I) | Lijuan Qiu |
| 16:50:00 | Structure Bioinformatics, TCM Databases, and Personalized Drug Design: Track 1-7 | Dong-Qing Wei |
| 16:50:00 | Identification of Master Control Genes for Protection against Oxidative Stress or for Protection against a Broad-spectrum Viral Infection : Track 1-3 | |
| 16:50:00 | Role of the Reduced Folate Carrier (RFC) in Intestinal Folate Uptake: Track 1-4 (II) | K. Balamurugan |
| 16:50:00 | Investigating the Genetics of Pre-eclampsia : Track 1-1 | Simmi Kharb |
| 16:50:00 | A Foot in Both Camps: Applying Philosophy to Gene Chip Versus Traditional Assessments of Kidney Transplant Biopsies: Track 1-6 (I) | Kim Solez |
| 16:55:00 | Role of miRNAs in Airway Hyper-Responsiveness and Goblet Cell Hyperplasia Associated with Allergic Asthma : Track 1-4 (I) | Preethi H. Gunaratne |
| 17:10:00 | SNP based Microarray Approach to Detect Imbalanced Allelic Expression: Track 1-5 (II) | Lei Li |
| 17:10:00 | A Fish Model for Testing siRNA Delivery and Side-effects : Track 1-4 (I) | Brian Dall Schyth |
| 17:10:00 | Human Genome, MHC-gene, HLA complex involved in Immune responses : Track 1-1 | Nitosh Kumar Brahma |
| 17:10:00 | Applications of Moving Reaction Boundary in Isoelectric Focusing and Free-flow Electrophoresis : Track 1-3 | Ke-Xi Cao |
| 17:10:00 | TBD | |
| 17:10:00 | Novel Thyroid Hormone Receptor Binding Sites and Target Genes Identified with ChIP-on-chip in Developing Mouse Cerebellum: Track 1-6 (I) | Hongyan Dong |
| 17:10:00 | Gentrepid: a Webserver for Computational Candidate Disease Gene Prediction: Track 1-7 | Jason Y. Liu |
| 17:30:00 | GenCLiP: A Software Program for Clustering Gene Lists by Literature Profiling and Constructing Gene Co-occurrence Networks Related to Custom Keywords: Track 1-7 | Zhong-Xi Huang |
| 17:50:00 | Announcements | |
| 18:00:00 | End of the day | |
| Saturday, December 6, 2008 | ||
| 07:50:00 | Session Chair :Track 1-6 (II) | Bimal K. , Ray |
| 07:55:00 | Track 1-6 (II): Gene Discovery Technologies | |
| 08:00:00 | Co-Chair :Track 1-6 (II) | |
| 08:55:00 | Track 2: Gene Technologies in New Drug Development and Medical Practice:Track 1-12 | |
| 08:55:00 | Co-Chair :Track 1-9 | |
| 08:55:00 | Session Chair :Track 1-6 (II) | |
| 08:55:00 | Co-Chair :Track 1-12 | |
| 08:55:00 | Co-Chair :Track 1-12 | Ravi Vinayak |
| 08:55:00 | Session Chair :Track 1-12 | |
| 08:55:00 | Track 1-9: Statistical and Computational Genomics :Track 1-6 (II) | |
| 08:55:00 | Track 1-12: Instrumentation for Genomic Analysis :Track 1-12 | |
| 08:55:00 | Co-Chair :Track 1-6 (II) | Akinori Takaoka |
| 08:55:00 | Track 2-1: Gene Tech in Molecular Diagnostics, Prognostics and Personalized Medicine :Track 1-12 | |
| 08:55:00 | Session Chair :Track 1-9 | |
| 08:55:00 | Session Chair :Track 1-12 | Pavel Hamet |
| 09:00:00 | Session Introduction :Track 1-12 | |
| 09:00:00 | Track 1-8: Chromosomes / DNA Dynamics :Track 1-6 (II) | |
| 09:00:00 | Introduction :Track 1-10 | |
| 09:00:00 | Track 1-10: Genetic Toxicology and ADME/T | |
| 09:00:00 | Introduction :Track 1-9 | |
| 09:00:00 | Introduction :Track 1-6 (II) | |
| 09:00:00 | Introduction :Track 1-6 (II) | |
| 09:00:00 | Introduction :Track 1-12 | |
| 09:05:00 | TBD:Track 1-10 | |
| 09:05:00 | Speech Opportunity Available :Track 1-6 (II) | |
| 09:05:00 | Handling the Bottle Necks of New Generation Sequencing using Old Generation Methods:Track 1-12 | Raja Mugasimangalam |
| 09:05:00 | Personalized medicine in the treatment of autoimmunity:Track 1-12 | Cor Verweij |
| 09:05:00 | Speech Opportunity Available :Track 1-9 | |
| 09:05:00 | Speech Opportunity Available :Track 1-6 (II) | |
| 09:25:00 | Antigen/Biomarker Discovery Using High throughput Proteomics Tools :Track 1-12 | Xiaowu Liang |
| 09:25:00 | TBD | Yu-Li Wang |
| 09:25:00 | Progress in Non-invasive Prenatal Diagnosis of Common Aneuploidies :Track 1-6 (II) | Maj Hulten |
| 09:25:00 | Linkage Disequilibria Analysis of Multilocus Multiallelic Markers in Outcrossing Populations:Track 1-9 | Arthur Berg |
| 09:25:00 | Speech Opportunity Available :Track 1-6 (II) | |
| 09:30:00 | Plasmon-Controlled Fluorescence: A New Paradigm in Fluorescence Spectroscopy:Track 1-12 | Joseph R Lakowicz |
| 09:45:00 | TBD :Track 1-6 (II) | Jacques S. , Beckmann |
| 09:45:00 | Computing Genetic Imprinting of Haplotypes in Case-Control Studies:Track 1-9 | Tian Liu |
| 09:45:00 | Speech Opportunity Available :Track 1-10 | |
| 09:45:00 | Will Total Genome Scans Help Us With Predictive Power in Personalized Medicine:Track 1-12 | Pavel Hamet |
| 09:45:00 | Gene Regulation and its Implications:Track 1-6 (II) | Bimal K. , Ray |
| 09:55:00 | Title: TBD :Track 1-12 | Ravi Vinayak |
| 10:05:00 | Coffee Break :Track 1-10 | |
| 10:05:00 | Statistical and Computational Pharamcogenomics: Computing Genes for Drug Response:Track 1-9 | Rongling , Wu |
| 10:05:00 | Isolation of Heat Shock Protein gene from Gossypium Arboreum and Transformation in G. Hirsutm:Track 1-6 (II) | Tayyab Husnain |
| 10:05:00 | The Role of Histone Demethylation in De Novo DNA Methylation and Gene Silencing:Track 1-6 (II) | Yuehui He |
| 10:05:00 | The Impact Next Generation Sequencing on Genetic Diagnosis and Documentation of Human Genetic Variation:Track 1-12 | Graham Taylor |
| 10:20:00 | Introduction :Track 1-11 | |
| 10:20:00 | Session Chair :Track 1-11 | Sui Huang |
| 10:20:00 | New Cloning Technologies Gene Expression Profiling :Track 1-11 | |
| 10:25:00 | Coffee Break :Track 1-6 (II) | |
| 10:25:00 | Coffee Break :Track 1-12 | |
| 10:25:00 | Coffee Break :Track 1-6 (II) | |
| 10:25:00 | Multiway Real-time PCR Gene Expression Profiling in Yeast Saccharomyces Cerevisiae Reveals Altered Transcriptional Response of ADH-genes to Glucose Stimuli:Track 1-11 | Mikael Kubista |
| 10:25:00 | Coffee Break :Track 1-12 | |
| 10:40:00 | Finding Genes for Complex Human Traits :Track 1-6 (II) | Yurii , Aulchenko |
| 10:40:00 | Gene Regulation and Chromatin Dynamics by Chemical and Natural Products:Track 1-6 (II) | Guy Haegeman |
| 10:40:00 | How to Estimate Tens of Thousands of Parameters in an Epistatic Genetic Model:Track 1-9 | Yuan-Ming Zhang |
| 10:40:00 | The identification of Hepatitis B and Hepatitis C among street children in by PCR Tehran, Iran:Track 1-12 | F. Fallah |
| 10:40:00 | Speech Opportunity Available :Track 1-12 | |
| 10:40:00 | GENETIC SCREENING FOR SPORADIC CANCERS AND OTHER DISEASES OF COMPLEX AETIOLOGY:Track 1-12 | Varun Kesherwani |
| 10:45:00 | High order nuclear structure and gene expression in cancer cells :Track 1-11 | Sui Huang |
| 11:00:00 | Title: TBD :Track 1-6 (II) | Juraj Gregan |
| 11:00:00 | A New Way for Analysing Nucleotide Sequences:Track 1-9 | Thomas Wilhelm |
| 11:00:00 | T-DNA based Insertional Mutagenesis for Gene and Promoter Discovery in Arabidopsis :Track 1-6 (II) | Ramamurthy Srinivasan |
| 11:05:00 | Title: TBD :Track 1-11 | Imre Berger |
| 11:05:00 | Speech Opportunity Available :Track 1-12 | |
| 11:20:00 | A Novel Multiplex qPCR Assay for the Early Prediction of Sepsis in Critical Ill Patients Suffering from Shock and Organ Dysfunction:Track 1-12 | Stefan Russwurm |
| 11:20:00 | Gene-Gene Interaction Analysis for the Genome-wide Association Studies :Track 1-9 | Taesung Park |
| 11:20:00 | FMR1 gene as a model for neurodevelopmental and neuro degeneration diseases:Track 1-6 (II) | Sebastien Jacquemont |
| 11:20:00 | DNA Sensing Mechanism for the Activation of Innate Immune Responses:Track 1-6 (II) | Akinori Takaoka |
| 11:25:00 | High-throughput Gene Expression Profiling of Single Cells :Track 1-11 | Honghua Li |
| 11:30:00 | Discussion :Track 1-12 | |
| 11:40:00 | Discussion:Track 1-6 (II) | |
| 11:40:00 | Discussion:Track 1-6 (II) | |
| 11:40:00 | An Efficient Strategy for Solving Remote Homologue Modeling and Alignment:Track 1-9 | Huisheng Fang |
| 11:45:00 | Speech Opportunity Available :Track 1-11 | |
| 12:00:00 | Session Chair :Track 1-10 | James Jianguo Li |
| 12:00:00 | Discussion :Track 1-9 | |
| 13:00:00 | Session Chair :Track 2-4 (I) | David H. Kirn |
| 13:00:00 | Track 2-4 (II): Gene Therapy for Cancers (II) | |
| 13:00:00 | Track 2-8: Gene Therapy for Metabolic Diseases | |
| 13:00:00 | Track 2-7: Gene Therapy for Cardiovascular Disorders :Track 2-7 | |
| 13:00:00 | Session Chair | Hui Ge |
| 13:00:00 | Session Chair :Track 2-5 | Kenneth Lundstrom |
| 13:00:00 | Track 2-6: Gene Therapy for CNS Disorders :Track 2-5 | |
| 13:00:00 | Session Chair :Track 2-5 | |
| 13:00:00 | Session Chair :Track 2-8 | |
| 13:00:00 | Track 2-2: Validation of Functional Gene Target and Biomarker | |
| 13:00:00 | Session Chair :Track 2-7 | Aravinda Nanjundappa |
| 13:00:00 | Track 2-3: Gene Based Drug Discovery From Lead to Drug Candidates :Track 2-3 | Hui Ge |
| 13:00:00 | Co-Chair :Track 1-12 | Ian G Macreadie |
| 13:00:00 | Track 2-5: Gene Therapy for Infectious Diseases | |
| 13:00:00 | Co-Chair :Track 2-3 | |
| 13:00:00 | Session Chair :Track 1-12 | Michael N. Liebman |
| 13:00:00 | Co-Chair :Track 2-4 (II) | |
| 13:00:00 | Track 2-4 (I): Gene Therapy for Cancers (I) | |
| 13:00:00 | Session Chair :Track 2-4 (II) | |
| 13:05:00 | Co-Chair :Track 2-8 | Zhen Y. Jiang |
| 13:05:00 | Co-Chair :Track 2-4 (I) | Cheng Qian |
| 13:05:00 | Co-Chair :Track 2-7 | |
| 13:05:00 | Call for Co-Chair :Track 2-5 | |
| 13:10:00 | Co-Chair | |
| 13:30:00 | Introduction :Track 1-12 | |
| 13:30:00 | Introduction :Track 2-5 | |
| 13:30:00 | Introduction :Track 2-3 | |
| 13:30:00 | Introduction :Track 2-4 (I) | |
| 13:30:00 | Introduction :Track 2-4 (II) | |
| 13:30:00 | Introduction :Track 2-7 | |
| 13:30:00 | Introduction :Track 2-5 | |
| 13:30:00 | Introduction :Track 2-8 | |
| 13:35:00 | A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer (FP253-GDEPT):Track 2-2 | Andrew M Bray |
| 13:35:00 | Speech Opportunity Available :Track 2-7 | |
| 13:35:00 | Keynote Speech: Potential Speaker's Profile | |
| 13:35:00 | Speech Opportunity Available :Track 2-5 | |
| 13:35:00 | The Development of Broad Spectrum Antiviral Drugs: A New Strategy :Track 2-3 | Eleanor N Fish |
| 13:35:00 | Radiosensitization By Antisense Anti-MDM2 Mixed-Backbone Oligonucleotide in In Vitro and In Vivo Human Cancer Models :Track 2-4 (II) | James A. Bonner |
| 13:35:00 | Gene Therapy for HIV: Progress and Relationship to Anti-retroviral Therapy :Track 2-5 | Geoff Symonds |
| 13:35:00 | Armed Oncolytic Poxivurses for Cancer; a Novel Multi-mechanistic Product Class :Track 2-4 (I) | David H. Kirn |
| 13:55:00 | Genotype-Dependency of Risk of Radiation Exposure – Is Mammography Truly Beneficial for Women at High Risk of Breast Cancer :Track 2-4 (II) | Ranajit Chakraborty |
| 13:55:00 | Speech Opportunity Available :Track 2-3 | |
| 13:55:00 | Hypersensitive Estrogen Receptor in Premalignant Breast :Track 2-2 | Suzanne AW Fuqua |
| 13:55:00 | History Synthetic Biology Witnessing Synthetic Biology From its Beginnings ? :Track 2-4 (I) | Waclaw Szybalski |
| 13:55:00 | Targeting Nrf2 Pathway against Cardiovascular Disease :Track 2-7 | |
| 14:00:00 | Title: TBD :Track 2-5 | Artem Cherkasov |
| 14:00:00 | Recent Positive Selection Enriched in Regions near Brain-related Genes in Human :Track 2-5 | Haipeng Li |
| 14:00:00 | Analyzing Insulin Signaling Networks and Metabolic Functions Using Quantitative Proteomics Approach :Track 2-8 | Zhen Y. Jiang |
| 14:15:00 | Antimetastatic Activity of RNase A and DNase I :Track 2-4 (II) | Marina A. Zenkova |
| 14:15:00 | Gene therapy for Treatment of Peripheral Arterial Disease.:Track 2-7 | Aravinda Nanjundappa |
| 14:15:00 | Developing a Portfolio of Novel Drugs in Cancer & Pain with Proven Disruptive Drug Design Product Engine :Track 2-3 | Jay Wu |
| 14:15:00 | Title: TBD :Track 2-2 | |
| 14:15:00 | Function of Cellular Topoisomerases (I, IIα and IIβ) During Replication of Adenovirus – Implications in cancer therapy :Track 2-4 (I) | Fernando Ferreira |
| 14:25:00 | Oral Delivery of Glucan Encapsulated siRNA to Macrophages Targeting Map4K4 Attenuates Systemic Inflammation :Track 2-8 | Myriam Aouadi |
| 14:25:00 | Title: TBD :Track 2-5 | CC Khor |
| 14:25:00 | Alphavirus-based Gene Therap :Track 2-5 | |
| 14:35:00 | The Use of Yeast to Develop Chemo Protectives of The Human Brain :Track 2-2 | Ian G Macreadie |
| 14:35:00 | The Prospect of Biologics.:Track 2-3 | Hui Ge |
| 14:35:00 | Genomic and Clinicopathological Events in Hereditary Breast Cancer Focusing on Therapeutical Aspects :Track 2-4 (II) | Sigurdur Ingvarsson |
| 14:35:00 | Site-specific Gene Delivery into Cardiovascular System:Track 2-7 | Chunxian Song |
| 14:35:00 | Small Molecule Inhibitors Targeting Mutation Driven Cancers :Track 2-4 (I) | Jeannie Hou |
| 14:50:00 | Title: TBD :Track 2-5 | Rupshi Mitra |
| 14:50:00 | Developmental Origin of Adipose Tissue: Novel Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism :Track 2-8 | Yu-Hua Tseng |
| 14:50:00 | Title: TBD :Track 2-5 | Huanliang Liu |
| 14:55:00 | Speech Opportunity Available :Track 2-2 | |
| 14:55:00 | Targeted Gene Therapy in Small Cell Lung Cancer :Track 2-4 (I) | Hans Skovgaard Poulsen |
| 14:55:00 | Biopharmaceuticals in Plants; Toward the Next Century of Medicine:Track 2-3 | K. L., Hefferon |
| 14:55:00 | Stem Cell Gene Therapy for Cancers :Track 2-4 (II) | Win-Ping Deng |
| 14:55:00 | New Biomarkers of Neovascularization in Development of Haemorrhagic Unstable plaques: What are the Possibilities for Novel Nanotechnological Angiogenic Therapies? :Track 2-7 | Mark Slevin |
| 15:05:00 | Speech Opportunity Available :Track 2-5 | |
| 15:15:00 | Coffee Break :Track 2-5 | |
| 15:15:00 | Coffee Break :Track 2-4 (I) | |
| 15:15:00 | Coffee Break :Track 2-7 | |
| 15:15:00 | Coffee Break :Track 2-3 | |
| 15:15:00 | Coffee Break :Track 2-2 | |
| 15:15:00 | Coffee Break :Track 2-4 (II) | |
| 15:15:00 | Coffee Break :Track 2-5 | |
| 15:15:00 | Coffee Break :Track 2-8 | |
| 15:30:00 | Mechanisms that Explain the Lower Incidence of Breast Cancer in Postmenopausal Women Treated with Conjugated Equine Estrogens. Role of Estrogen Receptor Alpha and Beta :Track 2-4 (II) | Bhagu Bhavnani |
| 15:30:00 | Speech Opportunity Available :Track 2-8 | |
| 15:30:00 | Genetic Mechanism with Huntington Disease Patients:Track 2-5 | Gettig Elizabeth |
| 15:30:00 | The Epithelial Sodium Channel -α Subunit Splice Variant b (α ENaC b): Impact on Drug Discovery and Development :Track 2-7 | |
| 15:30:00 | Genetic Mechanism with Huntington Disease Patients :Track 2-5 | Gettig Elizabeth |
| 15:30:00 | Title: TBD :Track 2-2 | |
| 15:30:00 | The Genes Implicated to The Initiation and Progression of Brain Tumours :Track 2-4 (I) | Vadim M. Kavsan |
| 15:30:00 | Speech Opportunity Available :Track 2-5 | |
| 15:30:00 | Pharmacogenetics in Gastrointestinal Cancers:Track 2-3 | |
| 15:50:00 | Cell Nanomechanics as a Marker for Cancer :Track 2-2 | Jianyu Rao |
| 15:50:00 | HGF Gene Therapy as Vascular Regeneration Stimulating Drug :Track 2-7 | Ryuichi Morishita |
| 15:50:00 | SiRNA Therapy of Scar Formation in Spinal Cord Traumatic Injury:Track 2-5 | Alain M. Privat |
| 15:50:00 | Dendritic Cells Infected with Sendai Virus Vector, a Powerful Stimulator for Cancer Immunities :Track 2-4 (II) | Yasuji Ueda |
| 15:50:00 | Title: TBD :Track 2-3 | Yuan-Hua Ding |
| 15:50:00 | Challenges and Opportunities in Gene Therapy of Cancers :Track 2-4 (I) | Cheng Qian |
| 15:55:00 | An Important Diabetes Susceptibility Gene, Namely TCF 7L 2 :Track 2-8 | Tianru Jin |
| 16:10:00 | Molecular Characterisation of Prostate Cancer Biomarkers :Track 2-2 | Claire Hastie |
| 16:10:00 | "BioKnife" as a New Class of Genetically Engineered Anticancer Drug Based on Fusion Activity of Recombinant Sendai Virus :Track 2-4 (I) | Hiroaki Kinoh |
| 16:10:00 | Adenoviral and Adeno-Associated Viral Vector-Mediated Gene Transfer for the Treatment of Ocular Neovascularization :Track 2-5 | Keisuke , Mori |
| 16:10:00 | A Platform for Novel Drug Discovery: Identification of an Unique Estrogen Antagonist Effective Against Tamoxifen-resistant Breast Cancer :Track 2-3 | Steven K. Nordeen |
| 16:10:00 | New Gene Causing Familial Pituitary Adenomas, called AIP :Track 2-4 (II) | Márta Korbonits |
| 16:10:00 | New Gene Causing Familial Pituitary Adenomas, called AIP:Track 2-4 (II) | Márta Korbonits |
| 16:10:00 | Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome :Track 2-7 | Sunyoung Kim |
| 16:10:00 | A Platform for Novel Drug Discovery: Identification of an Unique Estrogen Antagonist Effective Against Tamoxifen-resistant Breast Cancer :Track 2-3 | Steven K. Nordeen |
| 16:20:00 | Title: TBD :Track 2-5 | Viroj Wiwanitkit |
| 16:20:00 | Speech Opportunity Available :Track 2-8 | |
| 16:30:00 | Title: TBD:Track 2-2 | Dihua Yu |
| 16:30:00 | Discussion:Track 2-3 | |
| 16:30:00 | Discussion :Track 2-7 | |
| 16:30:00 | Speech Opportunity Available :Track 2-5 | |
| 16:30:00 | Gene Expression studies in Cervical Cancer :Track 2-4 (I) | Thangarajan , Rajkumar |
| 16:30:00 | Role of Stress in DNA Damage and Progression of Cancer :Track 2-4 (II) | Naheed , Banu |
| 16:45:00 | Discussion :Track 2-5 | |
| 16:45:00 | Discussion :Track 2-8 | |
| 16:50:00 | Targeted Gene Delivery In Vivo for Cancer :Track 2-4 (II) | Frederick L. Hall |
| 16:50:00 | Speech Opportunity Available :Track 2-4 (I) | |
| 17:00:00 | End of the day | |
| Sunday, December 7, 2008 | ||
| 08:00:00 | Track 2-10: Gene Therapy for Autoimmune Diseases:Track 2-10 | |
| 08:00:00 | Session Chair :Track 2-12 | Lawrence Sherman |
| 08:00:00 | Track 2-9: Gene Therapy for Inflammation Diseases | |
| 08:00:00 | Session Chair :Track 2-10 | |
| 08:00:00 | Track 2-11: Gene Therapy for Other Major Diseases | |
| 08:05:00 | Co-Chair :Track 2-10 | |
| 08:05:00 | Session Chair :Track 2-9 | |
| 08:05:00 | Co-Chair :Track 2-12 | Michael Herr |
| 08:20:00 | Co-Chair :Track 2-9 | |
| 08:30:00 | Track 3-3: Detection and Biodegradation of Highly Toxic Biological Products and Microbes | |
| 08:30:00 | Session Chair : Track 3-3 | |
| 08:40:00 | Session Chair | |
| 08:50:00 | Track 3-1: Bioremediation of Industrial and City Waste with Genetic Engineering Strains: Track 3-1 | |
| 08:55:00 | Session Chair :Track 2-10 | |
| 08:55:00 | Track 3: Environmental Gene Technology | |
| 08:55:00 | Track 2-12: Genetic Screening and Gene Therapy Management in Clinical Practice | |
| 09:00:00 | Introduction :Track 2-12 | |
| 09:00:00 | Introduction :Track 2-9 | |
| 09:00:00 | Introduction : Track 3-3 | |
| 09:00:00 | Introduction :Track 2-10 | |
| 09:00:00 | Introduction :Track 2-10 | |
| 09:00:00 | Co-Chair :Track 2-10 | Rajni , Rani |
| 09:00:00 | Introduction :: Track 3-1 | |
| 09:05:00 | Speech Opportunity Available : Track 3-1 | |
| 09:05:00 | Keynote Speech: :Track 2-9 | |
| 09:05:00 | Meeting the Genomic Educational Needs of Clinicians Through Continuing Medical Education:Track 2-12 | Lawrence Sherman |
| 09:05:00 | Speech Opportunity Available :Track 2-10 | |
| 09:05:00 | Fetal Gene Therapy: Current Status and Future Perspective :Track 2-11 | Daniel Surbek |
| 09:05:00 | Speech Opportunity Available : Track 3-3 | |
| 09:25:00 | Approaches to the treatment of hearing and vision disorders:Track 2-12 | William J. Kimberling |
| 09:25:00 | Title: TBD : Track 3-3 | Peter A. Altman |
| 09:25:00 | Title: TBD : Track 3-1 | Olga Barrat |
| 09:25:00 | Title: TBD :Track 2-10 | Andras Perl |
| 09:30:00 | New Non-viral Methods of Gene Transfer Targeted to Hepatocytes:Track 2-11 | Jayanta Roy-Chowdhury |
| 09:30:00 | Biological Comparison of Human Anti-AMA1 IgGs :Track 2-9 | Kazutoyo Miura |
| 09:45:00 | Development of Lentiviral Vectors for Studying on Gene Function, Gene Discovery and Gene Therapy :Track 2-12 | Zhennan , Lai |
| 09:45:00 | Title: TBD : Track 3-1 | Harinder Singh |
| 09:45:00 | Systemic Sclerosis: from Bench to Bedside. Insights into Treatment :Track 2-10 | Lazaros I Sakkas |
| 09:45:00 | Speech Opportunity Available : Track 3-3 | |
| 09:55:00 | Up date of Genetic studies of Allergies and Asthma:Track 2-11 | Malcolm Blumenthal |
| 09:55:00 | Anti-Inflammatory Senescence Actives 5203-L Molecule to Promote Healthy Aging and Prolongation of Lifespan :Track 2-9 | Patrizia d'Alessio |
| 10:05:00 | Gene Copy Number Variations in Human Lupus :Track 2-10 | Yu Chack-Yung |
| 10:05:00 | Speech Opportunity Available : Track 3-1 | |
| 10:05:00 | Putative Neuroligin 4 Mutations Occur in 3-4% of Clinical Samples from U.S. Caucasian Patients with Asperger Syndrome and Autism:Track 2-12 | Juan-Sebastian Saldivar |
| 10:05:00 | Speech Opportunity Available : Track 3-3 | |
| 10:20:00 | Coffee Break :Track 2-11 | |
| 10:20:00 | Coffee Break :Track 2-9 | |
| 10:25:00 | Coffee Break : Track 3-3 | |
| 10:25:00 | Coffee Break : Track 2-10 | |
| 10:25:00 | Coffee Break :Track 2-12 | |
| 10:25:00 | Coffee Break : Track 3-1 | |
| 10:35:00 | Track 3-2: Gene Technologies for Development of Green Clean Products: Track 3-2 | |
| 10:40:00 | Speech Opportunity Available | |
| 10:40:00 | Immunogenetic Basis of Auto-immune Responses in Type 1 Diabetes in North Indian patients: Track 2-10 | Rajni , Rani |
| 10:40:00 | Systematic Resequencing of the Coding Exons of the X Chromosome in X-linked Mental Retardation:Track 2-11 | Jozef , Gecz |
| 10:40:00 | Introduction : Track 3-2 | |
| 10:40:00 | Session Chair : Track 3-2 | |
| 10:40:00 | BREAST CANCER: ABREAST WITH TECHNOLOGY :Track 2-12 | Shikha Tarang |
| 10:45:00 | Speech Opportunity Available : Track 3-2 | |
| 11:00:00 | Funding from the Laboratory to Pre-clinical validation and then Clinical validation :Track 2-12 | Michael Herr |
| 11:00:00 | Gene Therapy for Allergic Diseases :Track 2-10 | Bor-Luen Chiang |
| 11:05:00 | Speech Opportunity Available :Track 2-11 | |
| 11:05:00 | Interaction of XRCC1, CCND1 and GSTM1 Gene Polymorphisms with Tobacco Exposure in Modification of the Risk of Oral Leukoplakia :Track 2-9 | Binod , Kumar Yadav |
| 11:05:00 | Title: TBD: Track 3-2 | Calvin B Harley |
| 11:20:00 | Genetics of Metabolic Bone Disorders: from Predisposition Genes to Targeted Personalized Medicine:Track 2-12 | Luigi Gennari |
| 11:20:00 | Mannose Binding Lectin and Systemic Lupus Erythematosus:Track 2-10 | Mo-Yin Mok |
| 11:25:00 | Title: TBD: Track 3-2 | Eviatar Nevo |
| 11:30:00 | Discussion :Track 2-9 | |
| 11:30:00 | Speech Opportunity Available :Track 2-11 | |
| 11:40:00 | Discussion :Track 2-10 | |
| 11:40:00 | Speech Opportunity Available :Track 2-12 | |
| 11:45:00 | Title: TBD : Track 3-2 | Linda Scobie |
| 13:00:00 | Session Chair :Track 4-4 | |
| 13:00:00 | Track 4: Agricultural, Forest Tree, Marine & Food Gene Technology | |
| 13:00:00 | Co-Chair :Track 4-1 (I) | |
| 13:00:00 | Co-Chair :Track 4-3 | Roberto Tuberosa |
| 13:00:00 | Track 5-1: Gene Technology for High Yields Renewable Energy Plants | |
| 13:00:00 | Session Chair :Track 4-2 | Guihua Lu |
| 13:00:00 | Co-Chair :Track 4-2 | |
| 13:00:00 | Session Chair : Track 5-1 | |
| 13:00:00 | Session Chair :Track 4-1 (II) | Kathleen Hefferon |
| 13:00:00 | Track 4-2: Gene Engineering on Livestock, Fisheries and Aquaculture | |
| 13:00:00 | Track 4-3: Forest Tree Genes and Genomics | |
| 13:00:00 | Session Chair | |
| 13:00:00 | Track 5: Gene Technology for Sustainable Energy | |
| 13:00:00 | Track 4-1 (II): Transgenic Plants and Animal Bioreactors | |
| 13:00:00 | Session Chair | |
| 13:00:00 | Co-Chair :Track 4-1 (II) | |
| 13:00:00 | Session Chair : Track 4-2 | Sigurdur , Ingvarsson |
| 13:00:00 | Session Chair :Track 4-3 | |
| 13:00:00 | Session Chair | Om P. Rajora |
| 13:00:00 | Track 4-4: Gene Tech in Food Processing and Food Safety Testing | |
| 13:00:00 | Co-Chair | |
| 13:00:00 | Track 5-1: Gene Technology for High Yields Renewable Energy Plants : Track 5-1 | |
| 13:05:00 | Track 4-1 (I): Transgenic Plants and Animal Bioreactors | |
| 13:05:00 | Co-Chair : Track 5-1 | |
| 13:10:00 | Co-Chair | |
| 13:10:00 | Session Chair : Track 4-1 (I) | Hany A. El-Shemy |
| 13:15:00 | Co-Chair | Peng Zhang |
| 13:25:00 | Introduction :Track 4-1 (II) | |
| 13:30:00 | Session Introduction :Track 4-3 | |
| 13:30:00 | Introduction : Track 4-2 | |
| 13:30:00 | Introduction :Track 4-1 (I) | |
| 13:30:00 | Introduction : Track 5-1 | |
| 13:30:00 | Introduction : Track 4-4 | |
| 13:30:00 | Introduction :Track 4-2 | |
| 13:30:00 | Introduction :Track 4-1 (II) | |
| 13:35:00 | Sustainable Energy Future – Emerging Opportunities in Conventional Engineering Systems and Genetic Manipulation : Track 5-1 | Anil Kane |
| 13:35:00 | Title: TBD :Track 4-2 | Guihua Lu |
| 13:35:00 | Title: TBD :Track 4-1 (I) | Hamish Gordon Spencer |
| 13:35:00 | Bioengineered Crops as Tools for International Development: Opportunities and Strategic Considerations : Track 4-4 | PETER GREGORY |
| 13:35:00 | Biopharmaceuticals in plants; toward the next century of medicine :Track 4-1 (II) | Kathleen Hefferon |
| 13:35:00 | Plants for the Future :Track 4-3 | Roberto Tuberosa |
| 13:55:00 | Title: TBD : Track 4-4 | Jing X. Kang |
| 13:55:00 | We Are What We Eat - Truths and Fallacies of Bioengineered Foods :Track 4-1 (I) | Channapatna S. Prakash |
| 13:55:00 | Enzymatic Engineering of Porcine Biomedical Models :Track 4-2 | Scott C. Fahrenkrug |
| 14:00:00 | Molecular Breeding of Large Biomass Crops Such as Arundo Donax for Biomass Production and Remediation : Track 5-1 | Laszlo Marton |
| 14:00:00 | Transgenic Plants for Molecular Farming :Track 4-1 (II) | Gupta Mahesh |
| 14:00:00 | Genomics and Gene Technologies for Understanding and Improving Growth, Health and Adaptation to Climate Change in Forest Trees:Track 4-3 | Om P. Rajora |
| 14:00:00 | Transgenic Plants for Molecular Farming :Track 4-1 (II) | Gupta Mahesh |
| 14:15:00 | Speech Opportunity Available : Track 4-4 | |
| 14:15:00 | Title: TBD :Track 4-2 | Hamish G. Spencer |
| 14:15:00 | Transgenic Plants for Molecular Farming :Track 4-1 (I) | S. Mahesh |
| 14:25:00 | Speech Opportunity Available :Track 4-1 (II) | |
| 14:25:00 | Title: TBD :Track 4-3 | Stacey Lee Thompson |
| 14:35:00 | Gene-based Mobile and Digital Diagnostic Tools: High Lights from a Danish Project on Bird Flue : Track 4-4 | Jeffrey Hoorfar |
| 14:35:00 | Title: TBD :Track 4-1 (I) | Gary Comstock |
| 14:35:00 | Title: TBD :Track 4-2 | Roberto Tuberosa |
| 14:35:00 | Speech Opportunity Available : Track 5-1 | |
| 14:45:00 | Feedstock and Enzyme Improvement for Bioenergy : Track 5-1 | Joshua S. Yuan |
| 14:50:00 | Genetical Genomics of Spruce | Kermit Ritland |
| 14:50:00 | Speech Opportunity Available :Track 4-1 (II) | |
| 14:55:00 | Speech Opportunity Available :Track 4-2 | |
| 14:55:00 | The Role of Green Fluorescent Protein (GFP) in Transgenic Plants to Reduce the Epigenetic Phenomena:Track 4-1 (I) | Hany A. El-Shemy |
| 14:55:00 | Speech Opportunity Available : Track 4-4 | |
| 15:15:00 | Coffee Break : Track 4-4 | |
| 15:15:00 | Coffee Break : Track 5-1 | |
| 15:15:00 | Coffee Break :Track 4-2 | |
| 15:15:00 | Coffee Break :Track 4-1 (I) | |
| 15:15:00 | Coffee Break : Track 4-3 | |
| 15:15:00 | Coffee Break :Track 4-1 (II) | |
| 15:30:00 | Isolation of Heat Shock Protein gene from Gossypium Arboreum and Transformation in G. hirsutm:Track 4-1 (II) | Tayyab Husnain |
| 15:30:00 | Molecular Markers in Tree Genetic Resource Evaluation : Track 4-3 | K. Gurumurthi |
| 15:30:00 | Cassava Genetic Improvement for Food Security and Bioenergy Development | Peng Zhang |
| 15:30:00 | Crop Genome Modifications for Affordable Cellulosic Biofuels : Track 5-1 | Mariam Sticklen |
| 15:30:00 | Nutraceuticals from Underutilized Fruits and Vegetables and Development of Functional Food : Track 4-4 | S. M. Aradhya |
| 15:30:00 | Evaluation of yanyanku process and its aptitude to ferment African locust bean (Parkia biglobosa) to produce sonru, a food condiment consumed in Benin :Track 4-2 | Ir. Paulin AZOKPOTA |
| 15:50:00 | Standardization for Food Biotechnology - Are GM Foods OK : Track 4-4 | Madhulika , Prakash |
| 15:50:00 | Title: TBD:Track 4-1 (I) | Sharan Angadi |
| 15:50:00 | Antiviral Cell-mediated Immune Responses after DNA Vaccination in Rainbow Trout :Track 4-2 | Uwe Fischer |
| 15:55:00 | Speech Opportunity Available : Track 4-3 | |
| 15:55:00 | Wide Hybridization in Chickpea (Cicer arietinum L.) :Track 4-1 (II) | J.S. Sandhu |
| 15:55:00 | Speech Opportunity Available | |
| 16:10:00 | Genetic diversity of rice leaf blight bacterial strains ( Xanthomonas oryzae pv. oryzae) in Nothern of Vietnam. :Track 4-1 (I) | Phan Huu Ton |
| 16:10:00 | Bacteriophage-host Interactions and the Potential of Phage Therapy to Control Bacterial Infections in Aquaculture:Track 4-2 | Mathias Middelboe |
| 16:10:00 | Economics of Protein Malnutrition - Indian perspective : Track 4-4 | R. P. Sharma |
| 16:20:00 | Genetic Engineereing of Plant Cell Wall Polysaccharides | Gursharn S. Randhawa |
| 16:20:00 | Speech Opportunity Available | |
| 16:20:00 | Speech Opportunity Available : Track 4-3 | |
| 16:30:00 | Flavobacterium columnare: epidemiology and fish immune responses:Track 4-2 | Pin Nie |
| 16:30:00 | Development of a new thermo-sensitive genic male sterility line with bacterial blight resistance by molecular marker-assisted selection:Track 4-1 (I) | Vu Thi Thu Hien |
| 16:30:00 | Discussion : Track 4-4 | |
| 16:45:00 | Title: TBD :Track 4-1 (II) | Maurice S. B. Ku |
| 16:45:00 | Discussion : Track 4-3 | |
| 16:50:00 | Speech Opportunity Available :Track 4-1 (I) | |
How We Rank